Clinical Trial Update: Endothelial Progenitor Cells in Umbilical Cord Blood in Preeclampsia and IUGR

View source ↗

Summary

A clinical trial studying endothelial progenitor cells in umbilical cord blood for preeclampsia and intrauterine growth restriction has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrauterine Growth Restriction
• Preeclampsia

Snippet

Sponsor: Medical University of South Carolina | Conditions: Preeclampsia, IUGR | Status: TERMINATED